Characterization of differential antibody production against hepatitis C virus in different HCV infection status - Wikidata - wikimedia - TriplyDB

Characterization of differential antibody production against hepatitis C virus in different HCV infection status

Characterization of differential antibody production against hepatitis C virus in different HCV infection status

http://www.wikidata.org/entity/Q27469004

about

Anti-HCV immunoblot indeterminate results in blood donors: non-specific reactivity or past exposure to HCV?Performance of ANTI-HCV testing in dried blood spots and saliva according to HIV status.

P2860

Q40076257-BAE1EBC7-E2AB-4503-BD84-0F83E82B9D21 Q40343820-684A724A-E0B4-4B92-8A55-EBCC56EB68BD

P2860

Characterization of differential antibody production against hepatitis C virus in different HCV infection status

http://www.wikidata.org/entity/Q27469004

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Characterization of differenti ...... different HCV infection status

@ast

Characterization of differenti ...... different HCV infection status

@en

Characterization of differenti ...... different HCV infection status

@nl

type

label

Characterization of differenti ...... different HCV infection status

@ast

Characterization of differenti ...... different HCV infection status

@en

Characterization of differenti ...... different HCV infection status

@nl

prefLabel

Characterization of differenti ...... different HCV infection status

@ast

Characterization of differenti ...... different HCV infection status

@en

Characterization of differenti ...... different HCV infection status

@nl

P1433

Q27469004-1767E1E0-6AC1-4912-B932-EAC704031E6D

P1476

Q27469004-3C5FC818-6E9D-44EB-9770-59A88B702069

P2093

Q27469004-05478783-DFB0-4A8A-A5D9-F1933799A842

Q27469004-8371E936-5A10-40DD-88F9-AE6B49D2179B

Q27469004-87FFE5AF-DD1C-417A-8601-B56885AF6EB2

Q27469004-98EFA844-55CD-43B3-8DDF-2AE1B57145E1

Q27469004-E5B18811-E9EF-468B-BA53-942B9930D194

P2860

Q27469004-0660F5F1-F880-4C07-B777-B837F30FB7B9

Q27469004-1A7457EB-3913-4E38-AC69-6BC76FB18654

Q27469004-2CFBF17D-8DF1-4952-813C-F3833993A5FB

Q27469004-33D2D648-CF6F-4E9C-AE38-0956BE1ED9BB

Q27469004-44B867C8-8305-46FE-A782-578F9F104D90

Q27469004-45444713-163B-47ED-B423-8ACDEE736699

Q27469004-58AA3172-6CEE-45AD-A62D-BB72D783A08C

Q27469004-61DC12F0-27E5-4A8B-AB88-409D1AD830FC

Q27469004-68317BAE-9686-4A90-B3B3-DF5E70B5762E

Q27469004-6FF708F2-39A7-4BD7-A53D-93EC3D3F1E23

P2888

Q27469004-72063CFD-F848-4EDF-A327-F38D230D1419

P304

Q27469004-7E9EBC3A-84D9-4381-9DE6-4CBF52E59F46

P31

Q27469004-3B44E0C1-94F5-4F6C-98DB-273D1A12A314

P3181

Q27469004-C587CA8E-60AD-4380-82C3-7A27E0027260

P356

Q27469004-D8A7FA38-9476-4311-A3CD-47D8800F3C21

P433

Q27469004-DA36B893-CE27-4905-9E35-CCEC7F72578F

P478

Q27469004-D3C9A97D-EF43-4FCC-B210-24ACE0803711

P50

Q27469004-59DD897C-60C8-4964-B503-969490D8CEBE

Q27469004-BF07F811-09E0-40FF-9C3B-CA2B35595A35

P577

Q27469004-8B06B876-E49D-444A-9EF6-AD4BA5D8CCF4

P6179

Q27469004-7D427432-0121-4002-BD56-0A5A679FC4E2

P698

Q27469004-A2A38F2B-E57C-40A8-B0C4-299DE292FDA9

P921

Q27469004-E9DA15CD-AA2A-4AD2-A8DA-606DE0A07769

P932

Q27469004-2EC2E4AB-7540-486D-9426-0C877E927791

P3181

P356

S12985-016-0572-9

P1433

Virology Journal

P1476

Characterization of differenti ...... different HCV infection status

@en

P2093

Mona Rafik

http://www.w3.org/2001/XMLSchema#string

Nancy Samir

http://www.w3.org/2001/XMLSchema#string

Nesrine Mohammed

http://www.w3.org/2001/XMLSchema#string

Salwa Bakr

http://www.w3.org/2001/XMLSchema#string

Walid Abd ElHady

http://www.w3.org/2001/XMLSchema#string

P2860

Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation.

Synthesis of a novel hepatitis C virus protein by ribosomal frameshift

Hepatitis C virus core, NS3, NS4B and NS5A are the major immunogenic proteins in humoral immunity in chronic HCV infection

Replication of hepatitis C virus

Evolving epidemiology of hepatitis C virus

Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt

Cross-genotypic polyclonal anti-HCV antibodies from human ascitic fluid.

The clinical relevance of persistent recombinant immunoblot assay-indeterminate reactions: insights into the natural history of hepatitis C virus infection and implications for donor counseling.

Laboratory diagnostics for hepatitis C virus infection.

Identification of a human epitope in hepatitis C virus (HCV) core protein using a molecularly cloned antibody repertoire from a non-symptomatic, anti-HCV-positive patient.

P2888

s12985-016-0572-9

P304

116

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

338706

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/S12985-016-0572-9

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1039460935

http://www.w3.org/2001/XMLSchema#string

P698

27357382

http://www.w3.org/2001/XMLSchema#string

P921

P932

4928299

http://www.w3.org/2001/XMLSchema#string